Abbott to buy Facet Biotech
- March 10, 2010
Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, ... Read More
Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, ... Read More
Akermin Inc. said Tuesday it raised $10 million in its Series B financing round and will use the new funds to develop and bring to market its carbon-capture system for power ... Read More